Sellas Life Sciences Group Inc.SLS
Buy moreBuy more on a dip to our buy price, which is under today's $8.09.
- 2 good· Above 200-day
- 2 to watch· Below 50-day
$8.09−0.33 (−3.92%)
Price at 3:03 PM ET
After hours · opens in 17h 24mNext open: Friday, Nov 13, 9:30 AM ETNASDAQ · Healthcare · Small company
The price we'd buy SLS at comes with a free account
It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.
What would change it
Sources
- Yahoo Finance daily closes to Nov 10
Any one could move it to Keep
Compared with the S&P 500
24 points
worse in one day
54 points
worse in five trading days
+439% in a yearsince Nov 10, 2025
The news behind our call
SELLAS Life Sciences reported on Nov 11.
SELLAS has strong projected earnings growth.
Analysts currently favor SELLAS.
What changed
SELLAS ended the reported session modestly higher, but the print provided limited incremental fundamental information.
Financials
Revenue fell 87% between FY 2021 and FY 2022, to $1.0M. It burned $28.4M of free cash in the last twelve months.
Revenue
Net income
EPS (diluted)
Free cash flow
Margins
Cash and debt
- Cash and investments$138M
- Total debt$740K
It holds $138.3M in cash and investments against $740,000 of debt, which leaves $137.6M of net cash.
Key facts
- Company value
- $1.7B
- Today's range
- 8.018.40
- Past year's range
- 1.3915.46
- Yesterday's close
- $8.42
- Swings vs the market
- 2.4×bigger